Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications. [electronic resource]
Producer: 20210617Description: 471-485 p. digitalISSN:- 1742-4658
- Antineoplastic Agents, Phytogenic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carrier Proteins -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Databases, Genetic
- Datasets as Topic
- Deoxyglucose -- pharmacology
- Drug Synergism
- ErbB Receptors -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Glycolysis -- drug effects
- Humans
- Metabolome -- drug effects
- Paclitaxel -- pharmacology
- Proto-Oncogene Proteins c-myc -- genetics
- Signal Transduction
- Silybin -- pharmacology
- Survival Analysis
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.